Late-Life Depression: A Review

Tue, 1/27/09 - 5:44pm
0 Comments
4783 reads

Citation:

Pages 35 - 44

Authors:

Bidhan Das, MD, Michael Greenspan, MD,
Sunanda Muralee, MD, Christine J. Choe, MD,
and Rajesh R. Tampi, MD, MS

Author Affiliations:

Dr. Das is from Harvard
Medical School, Boston, MA;
Drs. Greenspan, Muralee, and Tampi are from Yale University School of Medicine, New Haven, CT;
and Dr. Choe is from Rush
University School of Medicine, Chicago, IL.

This article is no longer available for CME credit.

Introduction

Major depressive disorder (MDD) is undiagnosed in approximately half of all elderly persons with this disorder.1 Contributing to this fact is that elderly patients are more likely than their younger counterparts to see their primary care physician rather than a psychiatrist.2 Major depressive disorder is not uncommon, occurring in approximately 2% of all community-dwelling elderly.3,4 In primary care clinics, the prevalence increases to approximately 6-9%,5 while among the patients admitted to acute care hospitals, the prevalence is approximately 10-12%. Among all nursing home residents, 12-14% meet the criteria for MDD.6 However, the rates of depressive symptoms in general are much higher, with studies showing prevalence rates between 30% and 45%.3,7

Beyond its prevalence, geriatric depression has severe ramifications, carrying with it an increased risk of both morbidity and mortality. Elderly patients with depression have a 1.5-3 times increased morbidity and a lifetime suicide risk of approximately 15%, with almost 10% of these patients dying annually from suicide.3 Given this broad-reaching clinical significance, it is imperative for the primary care and the psychiatric community to appreciate the unique presentation, diagnosis, and treatment of MDD in geriatric patients as compared to the general population. In this article, we review late-life depression and highlight the issues that need to be considered in treating patients with this disorder.

Presentation and Diagnosis

The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM–IV-TR) defines MDD as a condition characterized by the presence of depressed mood or loss of interest or pleasure. Associated symptoms include changes in appetite or weight (5% of total body weight), sleep, energy, concentration, and psychomotor activity, as well as feelings of inappropriate guilt or worthlessness, and recurrent thoughts of death or suicide.
Although not part of any standardized classification system, late-life depression is generally described as depression arising in adults older than 65 years of age who have not had a previous history of mood disorder.6 Population studies reveal that the presentation profile of late-life depression is distinct from that of the younger population. In general, patients with late-life depression are less likely to have a family history of depression than their younger counterparts.8 Their symptoms are more likely to develop insidiously, and these patients are less likely than their younger counterparts to attribute their symptoms to depression as opposed to “the normal aging process.”3

References:

1. Mulsant BH, Ganguli M. Epidemiology and diagnosis of depression in late life.J Clin Psychiatry 1999;60 Suppl 20:9-15.
2. Unutzer J, Katon W, Russo J, et al. Patterns of care for depressed older adults in a large-staff model HMO. Am J Geriatr Psychiatry 1999;7(3):235-43.
3. Fountoulakis KN, O’Hara R, Iacovides A, et al. Unipolar late-onset depression: A comprehensive review. Ann Gen Hosp Psychiatry 2003;2(1):11.
4. Harman JS, Schulberg HC, Mulsant BH, Reynolds CF. The effect of patient and visit characteristics on diagnosis of depression in primary care. J Fam Pract 2001;50(12):1068.
5. Taylor WD, Doraiswamy PM. A systematic review of antidepressant placebo-controlled trials for geriatric depression: Limitations of current data and directions for the future. Neuropsychopharmacology 2004;29(12):2285-2299.
6. Alexopoulos GS. Depression in the elderly. Lancet 2005; 365(9475):1961-1970.
7. Alexopoulos GS. New concepts for prevention and treatment of late-life depression. Am J Psychiatry 2001;158(6):835-838.
8. Dunner DL. Treatment considerations for depression in the elderly. CNS Spectr 2003;8(12 Suppl 3):14-19.
9. Thorpe L. The treatment of psychotic disorders in late life. Can J Psychiatry 1997;42 Suppl 1:19S-27S.
10. Myers JK, Weissman MM, Tischler GL, et al. Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry 1984;41(10):959-967.
11. Gournellis R, Lykouras L, Fortos A, et al. Psychotic (delusional) major depression in late life: A clinical study. Int J Geriatr Psychiatry 2001;16(11):1085-1091. [Erratum in:Int J Geriatr Psychiatry 2002;17(3):296.]
12. Raskind MA. The clinical interface of depression and dementia. J Clin Psychiatry 1998;59 Suppl 10:9-12.
13. Reynolds CF 3rd, Smith GS, Dew MA, et al. Accelerating symptom-reduction in late-life depression: A double-blind, randomized, placebo-controlled trial of sleep deprivation. Am J Geriatr Psychiatry 2005;13(5):353-358.
14. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1982-1983;17(1):37-49.
15. Alexopoulos GS, Katz IR, Reynolds CF, et al. Pharmacotherapy of depression in older patients: A summary of the expert consensus guidelines. J Psychiatr Pract 2001;7(6):361-376.
16. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993;270(15):1819-1825. [Erratum in: JAMA 1994;271(14):1082.]
17. Carney RM, Freedland KE. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 2003;54(3):241-247.
18. Yaffe K, Blackwell T, Gore R, et al. Depressive symptoms and cognitive decline in nondemented elderly women: A prospective study. Arch Gen Psychiatry 1999;56(5):425-430.
19. Comijs HC, Jonker C, Beckman AT, Deeg DJ. The association between depressive symptoms and cognitive decline in community-dwelling elderly persons. Int J Geriatr Psychiatry 2001;16(4):361-367.
20. Wilson RS, Barnes LL, Mendes de Leon CF, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002;59(3):364-370.
21. Lockwood KA, Alexopoulos GS, van Gorp WG. Executive dysfunction in geriatric depression. Am J Psychiatry 2002;159(7):1119-1126.
22. Butters MA, Whyte EM, Nebes RD, et al. The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry 2004;61(6):587-595.
23. Ko DT, Hebert PR, Coffey CS, et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002;288(3):351-357.
24. Bruce ML. Psychosocial risk factors for depressive disorders in late life. Biol Psychiatry 2002;52(3):175-184.